Portal de Periódicos da CAPES

Endothelial Dysfunction

2003; Lippincott Williams & Wilkins; Volume: 108; Issue: 17 Linguagem: Inglês

10.1161/01.cir.0000099580.72044.83

1524-4539

James T. Willerson, Dean J. Kereiakes,

Nitric Oxide and Endothelin Effects

HomeCirculationVol. 108, No. 17Endothelial Dysfunction Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBEndothelial Dysfunction James T. Willerson and Dean J. Kereiakes James T. WillersonJames T. Willerson From St Luke's Episcopal Hospital/Texas Heart Institute (J.T.W.), Houston, Tex, and the Carl and Edyth Lindner Center for Research and Education (D.J.K.), Ohio Heart Health Center, Cincinnati, Ohio. and Dean J. KereiakesDean J. Kereiakes From St Luke's Episcopal Hospital/Texas Heart Institute (J.T.W.), Houston, Tex, and the Carl and Edyth Lindner Center for Research and Education (D.J.K.), Ohio Heart Health Center, Cincinnati, Ohio. Originally published28 Oct 2003https://doi.org/10.1161/01.CIR.0000099580.72044.83Circulation. 2003;108:2060–2061Drs Ganz and Vita1 and Verma, Buchanan, and Anderson2 have presented persuasive evidence that endothelial function is dynamically regulated and that the endothelium's vasodilator, antiinflammatory, and antithrombotic properties are markedly diminished by a variety of injuries, including atherosclerosis, hypertension, diabetes, inflammation, and aging. Moreover, they identify several recent studies that provide evidence that endothelial dysfunction in both coronary and peripheral arteries precedes the development of the clinical consequences of atherothrombosis. Testing of endothelial function still rests largely in the administration of an endothelium-dependent vasodilator, such as acetylcholine, or in evaluating brief periods of occlusion of an artery followed by functional assessment of that artery, which is vasodilation when normal and failure of vasodilation or vasoconstriction when abnormal. Quantitative coronary arteriography has been used in the past to measure coronary vasomotor responses, and more recently, ultrasound has been used as a noninvasive measurement of endothelial function, especially when examining brachial arteries.However, what is missing from these assessments is an evaluation of other aspects of endothelial function, including antithrombotic, metabolic, and antiinflammatory properties. It is likely that subtle or early injury to the endothelium alters only one or two of the endothelial functional properties, whereas more extensive injury alters most or all of endothelial function, hastening the development of atherothrombosis and progressive vascular disease. This is an area where development needs to occur so that one might be able to assess a broader array of endothelial functional properties, anticipating greater predictive ability with regard to acute coronary artery syndromes, cerebrovascular accidents, and/or complications of peripheral vascular disease. It is also necessary to develop improved noninvasive means of evaluating endothelial function in coronary arteries, cerebral arteries, and peripheral arteries that are not amenable to evaluation by noninvasive ultrasound at present. Future developments in these areas should allow broader interrogation of arteries in the human body and provide even greater insight into arteries at risk for atherothrombosis and its consequences.Drs Verma, Buchanan, and Anderson2 seek to identify one or more biomarker(s) of vascular disease that would serve as surrogates for endothelial dysfunction. They suggest C-reactive protein. However, the studies available thus far do not provide compelling evidence that alterations in any biomarker correlate specifically with endothelial dysfunction. One anticipates finding abnormal endothelial function in individuals with very elevated C-reactive protein as a consequence of acute coronary syndromes, cerebrovascular accidents, marked hyperlipidemia, etc. Future studies may indeed provide more evidence of selective or generalized endothelial dysfunction with elevations in C-reactive protein (or some other biomarkers), but this will still not provide direct insight into the arterial system that is involved.Thus, there is work to do in developing improved noninvasive imaging that can evaluate endothelial function in arteries throughout the body and in identifying biomarkers with sensitivity and specificity for detection of early and progressive endothelial dysfunction. Finally, information that establishes the protective effect of selected interventions that reverse inflammation, correct hyperlipidemia and systemic arterial hypertension, control blood sugars in diabetic patients, and reverse endothelial dysfunction in altering progressive atherothrombosis and its consequences is also needed. Nevertheless, endothelial functional testing broadly identifying dysfunction and its potential correction with medical intervention may prove to be one of the very important advances in noninvasive diagnosis and predicting prognosis in patients with vascular disease, once improved noninvasive imaging techniques are developed and further evidence is provided that reversal of endothelial dysfunction protects against progression of vascular disease.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.FootnotesCorrespondence to James T. Willerson, MD, SLEH/THI, 6720 Bertner Ave, Room B 524, Houston, TX 77030. E-mail [email protected]References1 Ganz P, Vita JA. Testing endothelial vasomotor function: nitric oxide, a multipotent molecule. Circulation. 2003; 108: 2049–2053.LinkGoogle Scholar2 Verma S, Buchanan M, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation. 2003; 108: 2054–2059.LinkGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Jeong H, Lee H, Cho J and Moon J (2020) Does 3-pentadecylcatechol, an urushiol derivative, get absorbed in the body? A rat oral administration experiment, Food Science and Biotechnology, 10.1007/s10068-020-00739-1, 29:7, (997-1005), Online publication date: 1-Jul-2020. Carmassi C, Cordone A, Pedrinelli V and Dell'Osso L (2020) PTSD and Cardiovascular Disease Brain and Heart Dynamics, 10.1007/978-3-319-90305-7_20-1, (1-23), . Carmassi C, Cordone A, Pedrinelli V and Dell'Osso L (2020) PTSD and Cardiovascular Disease Brain and Heart Dynamics, 10.1007/978-3-030-28008-6_20, (355-376), . Соломенчук Т, Процько В, Восух О and Хамуляк Х (2019) Effectiveness of Cardiometabolic Therapy in the Treatment of Acute Coronary Syndrome without ST-segment Elevation in Perimenopausal Women, Family Medicine, 10.30841/2307-5112.2.2019.175140, 0:2, (66-75) Zhang L, Dai F, Cui L, Zhou B and Guo Y (2017) Up-regulation of the active form of small GTPase Rab13 promotes macroautophagy in vascular endothelial cells, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 10.1016/j.bbamcr.2017.01.003, 1864:4, (613-624), Online publication date: 1-Apr-2017. Leung S, Zhang H, Lau C and Lin Z (2016) Attenuation of blood pressure in spontaneously hypertensive rats by acupuncture was associated with reduction oxidative stress and improvement from endothelial dysfunction, Chinese Medicine, 10.1186/s13020-016-0110-0, 11:1, Online publication date: 1-Dec-2016. Burg M and Soufer R (2016) Post-traumatic Stress Disorder and Cardiovascular Disease, Current Cardiology Reports, 10.1007/s11886-016-0770-5, 18:10, Online publication date: 1-Oct-2016. Iglesias D, Gómez Rosso L, Vainstein N, Meroño T, Lezón C and Brites F (2015) Vascular reactivity and biomarkers of endothelial function in healthy subjects exposed to acute hypobaric hypoxia, Clinical Biochemistry, 10.1016/j.clinbiochem.2015.06.007, 48:16-17, (1059-1063), Online publication date: 1-Nov-2015. Piccoli J, Manfredini V, Faoro D, Farias F, Bodanese L and Bogo M (2013) Association between endothelial nitric oxide synthase gene polymorphism ( -786T>C ) and interleukin-6 in acute coronary syndrome , Human & Experimental Toxicology, 10.1177/0960327113499046, 33:4, (396-402), Online publication date: 1-Apr-2014. Zhang Z, Wang M, Xue S, Liu D and Tang Y (2011) Simvastatin Ameliorates Angiotensin II-Induced Endothelial Dysfunction Through Restoration of Rho-BH4-eNOS-NO Pathway, Cardiovascular Drugs and Therapy, 10.1007/s10557-011-6351-3, 26:1, (31-40), Online publication date: 1-Feb-2012. Munk P, Butt N and Larsen A (2011) Endothelial dysfunction predicts clinical restenosis after percutaneous coronary intervention, Scandinavian Cardiovascular Journal, 10.3109/14017431.2011.564646, 45:3, (139-145), Online publication date: 1-Jun-2011. Vita J and Hamburg N (2010) Does endothelial dysfunction contribute to the clinical status of patients with peripheral arterial disease?, Canadian Journal of Cardiology, 10.1016/S0828-282X(10)71062-X, 26, (45A-50A), Online publication date: 1-Mar-2010. Munk P, Staal E, Butt N, Isaksen K and Larsen A (2009) High-intensity interval training may reduce in-stent restenosis following percutaneous coronary intervention with stent implantation, American Heart Journal, 10.1016/j.ahj.2009.08.021, 158:5, (734-741), Online publication date: 1-Nov-2009. Nossaman B, Murthy S and Kadowitz P Disruption of the Nitric Oxide Signaling System in Diabetes Cardiovascular Endocrinology, 10.1007/978-1-59745-141-3_3, (35-59) Vogel R (2008) Listening to the Endothelium, Journal of the American College of Cardiology, 10.1016/j.jacc.2008.01.048, 51:20, (1965-1966), Online publication date: 1-May-2008. Bian K, Doursout M and Murad F (2008) Vascular System: Role of Nitric Oxide in Cardiovascular Diseases, The Journal of Clinical Hypertension, 10.1111/j.1751-7176.2008.06632.x, 10:4, (304-310), Online publication date: 1-Apr-2008. Balakumar P, Koladiya R, Ramasamy S, Rathinavel A and Singh M (2008) Pharmacological Interventions to Prevent Vascular Endothelial Dysfunction: Future Directions, JOURNAL OF HEALTH SCIENCEJournal of Health Science, 10.1248/jhs.54.1, 54:1, (1-16), . Chen W, Ho W, Chang G, Chen S, Pang J, Chou S, Tsay P and Kuo C (2008) Propylthiouracil, independent of its antithyroid effect, produces endothelium-dependent vasodilatation through induction of nitric oxide bioactivity, Atherosclerosis, 10.1016/j.atherosclerosis.2006.11.018, 196:1, (383-390), Online publication date: 1-Jan-2008. Pacher P, Beckman J and Liaudet L (2007) Nitric Oxide and Peroxynitrite in Health and Disease, Physiological Reviews, 10.1152/physrev.00029.2006, 87:1, (315-424), Online publication date: 1-Jan-2007. Bian K and Murad F (2007) Nitric oxide signaling in vascular biology, Journal of the American Society of Hypertension, 10.1016/j.jash.2006.11.007, 1:1, (17-29), Online publication date: 1-Jan-2007. Arbel Y, Dvir D, Feinberg M, Beigel R and Shechter M (2007) The association between right coronary artery morphology and endothelial function, International Journal of Cardiology, 10.1016/j.ijcard.2005.12.023, 115:1, (19-23), Online publication date: 1-Jan-2007. Falk E (2006) Pathogenesis of Atherosclerosis, Journal of the American College of Cardiology, 10.1016/j.jacc.2005.09.068, 47:8, (C7-C12), Online publication date: 1-Apr-2006. Kleinbongard P, Dejam A, Lauer T, Jax T, Kerber S, Gharini P, Balzer J, Zotz R, Scharf R, Willers R, Schechter A, Feelisch M and Kelm M (2006) Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans, Free Radical Biology and Medicine, 10.1016/j.freeradbiomed.2005.08.025, 40:2, (295-302), Online publication date: 1-Jan-2006. Mathru M and Lang J (2005) ENDOTHELIAL DYSFUNCTION IN TRAUMA PATIENTS: A PRELIMINARY COMMUNICATION, Shock, 10.1097/01.shk.0000174936.51903.7d, 24:3, (210-213), Online publication date: 1-Sep-2005. Tiong A and Brieger D (2005) Inflammation and coronary artery disease, American Heart Journal, 10.1016/j.ahj.2004.12.019, 150:1, (11-18), Online publication date: 1-Jul-2005. Patti G, Pasceri V, Melfi R, Goffredo C, Chello M, D'Ambrosio A, Montesanti R and Di Sciascio G (2005) Impaired Flow-Mediated Dilation and Risk of Restenosis in Patients Undergoing Coronary Stent Implantation, Circulation, 111:1, (70-75), Online publication date: 4-Jan-2005.Wang J, Normand S, Mauri L and Kuntz R (2004) Coronary Artery Spatial Distribution of Acute Myocardial Infarction Occlusions, Circulation, 110:3, (278-284), Online publication date: 20-Jul-2004. October 28, 2003Vol 108, Issue 17 Advertisement Article InformationMetrics https://doi.org/10.1161/01.CIR.0000099580.72044.83PMID: 14581385 Originally publishedOctober 28, 2003 PDF download Advertisement